首页> 外文OA文献 >Pharmacological neuroprotection of rat spinal locomotor networks against experimental spinal cord injury in vitro
【2h】

Pharmacological neuroprotection of rat spinal locomotor networks against experimental spinal cord injury in vitro

机译:大鼠脊髓运动神经网络对体外实验性脊髓损伤的药理神经保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Mammalian locomotor behaviour called fictive locomotion can be elicited in an isolated spinal cord in the absence of higher brain center or sensory input. This relatively simple behaviour is produced by the motoneuronal rhythmic activity which is under the control of spinal neuronal networks called central pattern generators (CPGs). Disturbance of this rhythmic motor output can occur following spinal cord injury (SCI). This elementary isolated spinal cord model gives us an opportunity to study the basic physiology of locomotion during control conditions, the pathological processes following lesion (which can be induced chemically), and eventually the application of therapeutic approaches curbing injury. udObjectives: Multiple aspects of spinal functions can be demonstrated by stimulating or/and blocking specific inputs and measuring the outputs using electrophysiological, immunohistochemical and calcium imaging tools. Using isolated neonatal rat spinal cords and organotypic spinal slices as SCI models, the basic mechanisms (such as dysmetabolic state or excitotoxicity) which can develop during the early phase of the lesion were addressed and studied. The injury was evoked chemically by applying either pathological medium (to mimic dysmetabolic/hypoxic conditions) or kainate (to produce excitotoxicity that completely abolishes fictive locomotion and network synaptic transmission) for 1 h. Fictive locomotion was examined stimulating the lumbar dorsal root and recording from the ipsilateral and ipsi-segmental ventral roots. Other network parameters were also studied such as synaptic transmission and rhythmicity. Various therapeutic drugs such as methylprednisolone sodium succinate (MPSS), propofol, nicotine and celastrol were used during or after the injury (to produce neuroprotection) and network properties were characterized during the treatment and after 24 h as well. Subsequently, the structural properties were monitored using different biomarkers (isolated spinal cord sectioned slices) and calcium imaging (here organotypic spinal slices were used). udResults and conclusions: We found that dose-dependent application of MPSS produced modest recovery of white matter damage evoked by pathological medium resulting in the emergence of sluggish chemically induced fictive locomotor patterns. However, it could not prevent damage (to gray matter) evoked by the excitotoxic agent kainate. Therefore, to provide better neuroprotection to gray matter, we tested the widely used intravenous anaesthetic propofol. This drug has shown comparatively good protection to spinal neurons and motoneurons in the gray matter. As it is an anesthetic it acted by depressing the functional network characteristics by lowering the N-methyl-D-aspartate (NMDA) and potentiating the γ aminobutyric acid (GABAA) mediated receptor responses. udThe next issue we addressed was to study the neuroprotective roles of nicotinic acetylcholine receptors (nAChRs) by using the receptor agonist nicotine. Recent studies have shown that nicotine could provide good neuroprotection to the rat brainstem. To further investigate its effect on the spinal cord, we applied nicotine at the same concentration used in previous studies in the brainstem: such a concentration was toxic to spinal ventral motoneurons. Therefore the correct dose of nicotine was optimized and was found to be ten times lower. Thus, satisfactory protective effects to spinal neurons and motoneurons and the fictive locomotor patterns were observed. These neuroprotective effects were replicated with calcium imaging by using organotypic spinal slice cultures. The mechanism of protection predominantly involved α4β2 and less α7 nAChRs. udIn addition, the subsequent goal of our study was to explore whether the motoneuron survival after excitotoxicity relies on cell expression of heat shock protein 70 (HSP70) or some other mechanisms. To test this hypothesis we used a bioactive drug, celastrol which induces the expression of HSP70. Prior application of the drug followed by kainate preserved network polysynaptic transmission and fictive locomotion, however, it could not reverse the depression of monosynaptic reflex responses. In vivo studies are necessary in the future to further investigate the long-term neuroprotective role of these drugs.
机译:背景:在没有较高的大脑中枢或感觉输入的情况下,可以在孤立的脊髓中引发称为虚构运动的哺乳动物运动行为。这种相对简单的行为是由在称为中央模式发生器(CPG)的脊髓神经元网络控制下的单神经节律性活动产生的。脊髓损伤(SCI)后可能会出现这种有节奏的运动输出紊乱。这种基本的分离脊髓模型使我们有机会研究控制条件下运动的基本生理学,病变后的病理过程(可以化学诱导)以及最终应用治疗性方法治疗损伤。目的:通过刺激或/和阻断特定的输入并使用电生理,免疫组织化学和钙成像工具测量输出,可以证明脊柱功能的多个方面。使用分离的新生大鼠脊髓和器官型脊髓切片作为SCI模型,研究并研究了在病变早期可能发展的基本机制(例如代谢异常或兴奋性毒性)。通过应用病理介质(模拟代谢不良/低氧状态)或红藻氨酸(产生兴奋性毒性,完全消除虚构的运动和网络突触传递)化学刺激1小时。检查了虚构的运动来刺激腰背根,并记录了同侧和同侧段腹侧根。还研究了其他网络参数,例如突触传递和节律。在损伤期间或之后(产生神经保护作用)使用了各种治疗药物,如甲基泼尼松龙琥珀酸钠(MPSS),丙泊酚,尼古丁和西那那尔,并在治疗期间和24小时后表征了网络特性。随后,使用不同的生物标记物(分离的脊髓切片)和钙显像(此处使用器官型脊髓切片)监测结构特性。 ud结果与结论:我们发现,MPSS的剂量依赖性应用可适度恢复病理介质引起的白质损伤,从而导致化学诱导的虚构运动模式的出现。但是,它不能防止兴奋性毒性物质海藻酸盐引起的损害(对灰质)。因此,为了对灰质提供更好的神经保护,我们测试了广泛使用的静脉麻醉药异丙酚。该药物对灰质中的脊髓神经元和运动神经元显示出相对较好的保护作用。由于它是麻醉剂,它通过降低N-甲基-D-天冬氨酸(NMDA)并增强γ氨基丁酸(GABAA)介导的受体反应来降低功能网络特性。 ud我们解决的下一个问题是通过使用受体激动剂尼古丁来研究烟碱乙酰胆碱受体(nAChRs)的神经保护作用。最近的研究表明,尼古丁可以为大鼠脑干提供良好的神经保护作用。为了进一步研究其对脊髓的作用,我们在脑干中使用了与先前研究相同的浓度的尼古丁:这样的浓度对脊髓腹侧运动神经元有毒性。因此,对尼古丁的正确剂量进行了优化,发现降低了十倍。因此,观察到对脊髓神经元和运动神经元的满意保护作用以及虚拟运动模式。这些神经保护作用通过使用器官型脊柱切片培养物在钙成像中得以复制。保护的机制主要涉及α4β2和较少的α7nAChRs。 ud此外,我们研究的后续目标是探讨兴奋性中毒后运动神经元的存活是否依赖于热休克蛋白70(HSP70)的细胞表达或其他机制。为了验证该假设,我们使用了一种生物活性药物Celastrol,它可以诱导HSP70的表达。在先于海因酸盐的药物的先期应用保持了网络的多突触传递和虚构的运动,但是,它不能逆转单突触反射反应的抑制。将来有必要进行体内研究,以进一步研究这些药物的长期神经保护作用。

著录项

  • 作者

    Kaur Jaspreet;

  • 作者单位
  • 年度 2017
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号